Bangladesh, Nov. 14 -- Beximco Pharmaceuticals posted a 8.3 per cent year-on-year increase in profit to Tk 2.60 billion in the first quarter of FY27, buoyed by higher sales, lower finance costs and increased other income despite a challenging business environment.

Advertisement The drug maker logged a profit of Tk 2.40 billion in the same quarter of the previous financial year, according to its unaudited financial statements published on Thursday.

Its revenue grew 6.3 per cent year-on-year to Tk 14.66 billion in the July-September quarter of FY27, driven partly by an expansion of its distribution network.

Sales of lifesaving medicines also recorded significant growth during the quarter, contributing to higher revenue and profitability...